30 November 2017:
Novartis has advised that the company has both received and released stock for supply locally of the following lines;
- ESTALIS CONT 50+140MCG
- ESTALIS SEQ 50MCG/50+ 140MCG
- ESTALIS SEQ 50MCG/50+ 250MCG
As a result the only remaining HRT line now still unavailable is ESTALIS CONT 50+250MCG
This line is confirmed for arrival into Sydney early next week - 4 December 2017.
Novartis is in the process of re-stocking wholesalers for all products and the products should be in pharmacies sometime next week.
Content updated 30 November 2017